-
Trifluoperazine 2HCl: Beyond Dopamine D2 Inhibition in Moder
2026-05-20
Explore how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, enables advanced neuropharmacology and cancer research. This article delivers a deep-dive into its molecular action, practical protocols, and unique assay insights for researchers.
-
Dimethyl Fumarate Inhibits cGAS-STING to Alleviate Liver I/R
2026-05-20
This study demonstrates that dimethyl fumarate (DMF) mitigates hepatic ischemia–reperfusion (I/R) injury by directly suppressing the cGAS-STING signaling pathway. The findings establish DMF as a mechanistically validated modulator of innate immune activation in the liver, revealing new therapeutic potential for targeting cGAS-STING in inflammatory diseases.
-
Annexin V: Mechanistic Leverage for Translational Apoptosis
2026-05-19
This thought-leadership article explores the mechanistic foundation and strategic utility of Annexin V, human recombinant, as a phosphatidylserine binding protein in advanced apoptosis research. Integrating recent structural insights, competitive benchmarking, and workflow guidance, we chart a translational path for deploying unlabeled and conjugated Annexin V in complex cell death assays—unpacking its impact on oncology, cardiovascular, and cell fate studies.
-
Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling in Molecular
2026-05-19
Cy5-UTP (Cyanine 5-UTP) is a fluorescent uridine triphosphate analog optimized for direct RNA labeling in in vitro transcription. It enables high-sensitivity detection of RNA probes for FISH, dual-color arrays, and mechanistic studies, with quantitative benchmarks validated in recent single-molecule FRET applications.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Axis Modul
2026-05-18
This study reveals that gramine, a natural indole alkaloid, selectively suppresses triple-negative breast cancer (TNBC) growth by inducing ferroptosis through modulation of the CUL3–MTDH axis. The findings offer mechanistic insight into ferroptosis regulation and highlight gramine as a promising candidate for targeted TNBC therapy.
-
G-1 (CAS 881639-98-1): Selective GPR30 Agonist in Research
2026-05-18
G-1 is a potent, selective agonist of the G protein-coupled estrogen receptor GPR30 (GPER1), widely used to dissect non-classical estrogen signaling. It demonstrates nanomolar affinity, minimal off-target effects, and robust functional outcomes in cancer and cardiovascular models. APExBIO’s G-1 product enables reproducible, high-specificity modulation of GPR30 in mechanistic and translational studies.
-
Annexin V, Human Recombinant: Precision Tool for Immune Cell
2026-05-17
Explore how Annexin V, a leading phosphatidylserine binding protein, enables advanced apoptosis assays and unlocks new insights in immune tolerance research. This article uniquely addresses its role in modeling immune cell dynamics relevant to preeclampsia.
-
Ginsenoside Rg1: Optimizing Neuroprotection and Immunomodula
2026-05-16
Unlock reproducible neuroimmune research with Ginsenoside Rg1, a triterpene saponin uniquely suited for apoptosis and inflammation studies. This guide delivers protocol enhancements, troubleshooting insights, and cross-study comparisons to maximize translational impact in neuroprotection and gut-immune-brain axis models.
-
HRP-Based Proximity Labeling Illuminates Cell-Surface Proteo
2026-05-15
Wu et al. introduce a detailed, HRP-catalyzed biotinylation protocol for systematic cell-surface protein identification in mouse brain tissue. This method enables high-resolution, cell-type-specific mapping of surface proteomes, providing new opportunities for studying intercellular signaling in health and disease.
-
Bradykinin B2 Receptors Inhibit Ileal Peristalsis via Pressu
2026-05-15
This study provides the first direct evidence that bradykinin B2 receptor activation inhibits the peristaltic reflex in guinea pig ileum by increasing the pressure threshold required for peristalsis. These findings refine understanding of enteric neurotransmission and have significant implications for hypertension research and the mechanistic study of ACE inhibitors.
-
A40926: Dalbavancin Precursor for Precision Antibacterial As
2026-05-14
A40926, a potent dalbavancin precursor, empowers targeted research on Gram-positive and multidrug-resistant bacteria with precise inhibition of cell wall synthesis. Its defined MIC values, robust fermentation yields, and reliable sourcing from APExBIO offer reproducibility and scalability for advanced antibacterial workflows.
-
KN-62 Enables Precision Inhibition of Calcium Signaling Path
2026-05-14
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, empowers researchers to dissect CaMKII-driven calcium signaling with exceptional selectivity. This guide covers optimized experimental workflows, troubleshooting strategies, and key innovations that set KN-62 apart for studies in metabolism, secretion, and cell cycle regulation.
-
PLGA Nano-Adjuvant Targets Mucosal Immunity in H9N2 Vaccinat
2026-05-13
This study introduces a novel PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly enhances both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. By enabling sustained antigen release and effective intestinal targeting, the platform advances approaches for vaccine efficacy and mucosal immunology research.
-
RG108: Advancing Non-Nucleosidic DNMT Inhibition in Translat
2026-05-13
Explore how RG108, a non-nucleosidic DNA methyltransferase inhibitor, disrupts conventional paradigms in epigenetic gene regulation modulation. Bridging mechanistic insight with strategic application, this article delivers actionable guidance for translational researchers seeking precision, scalability, and new frontiers in cancer and beyond.
-
Efficient iPSC-to-Retinal Ganglion Cell Differentiation via
2026-05-12
This study establishes a robust, chemically defined protocol using dual SMAD and Wnt pathway inhibition to reproducibly differentiate human iPSCs into retinal ganglion cells (RGCs) with high purity. The findings provide a scalable foundation for glaucoma modeling and retinal neurodegeneration research using patient-derived stem cells.